New-onset persistent hyperglycemia with initiation of brentuximab treatment
Journal of Oncology Pharmacy Practice
Published online on April 28, 2023
Abstract
Journal of Oncology Pharmacy Practice, Volume 32, Issue 3, Page 569-571, April 2026.
IntroductionThe addition of brentuximab vedotin (BV) to adriamycin, vinblastine, and dacarbazine (AVD) has become the standard-of-care approach for advanced stage Hodgkin lymphoma (HL). This case describes a rare presentation of new-onset diabetes ...
IntroductionThe addition of brentuximab vedotin (BV) to adriamycin, vinblastine, and dacarbazine (AVD) has become the standard-of-care approach for advanced stage Hodgkin lymphoma (HL). This case describes a rare presentation of new-onset diabetes ...